En
Da
Fr
De
Sv
Deal History
About us
The Company
Team
Offices
Globalscope
Newsletter
Services
Corporate Finance
Debt Advisory
Equity Research
Growth Equity Financing
IPO Strategy & Preparation
Industries
Business Services
Consumer & Internet
Industrial Technology
Life Science
Software & TMT
Energy & Infrastructure
Research
Equity Research
Macro and Markets
Career
Events
Insights
News
Company News
Deal News
In the Media
Contact
Newsletter
En
Da
Fr
De
Sv
Main menu button
Worldwide
Worldwide
Canada
Denmark
France
Germany
Poland
Sweden
United Kingdom
USA
Team
Deals
Contact
Worldwide
Worldwide
Canada
Denmark
France
Germany
Poland
Sweden
United Kingdom
USA
Team
Deals
Contact
News
All
Abera Bioscience
Adventure Box
Adverty
All for One Group
ALM Equity
Alzecure Pharma
Arctic Minerals
Biosergen
Candles Scandinavia
Carlsquare
CellaVision
CSAM Health Group
DanCann Pharma
Ecoclime
Elicera Therapeutics
Enrad
Frequentis
FRISQ
Future Gaming
GHP Specialty Care
GIAB
H&D Wireless
Hanza
Herantis Pharma
InCoax
Kancera
Medclair Invest
Midsummer
Mindark PE
Modus Therapeutics
Moninvent
NeoDynamics
Nischer Properties
Nosa Plugs
Observit
Orion Corporation
Pharmiva
Raytelligence
Risk Intelligence
SBB i Norden
Sensec
Spotlight Group
Svenska Aerogel
Thinc Jetty
Viva Wine Group
Ytrade Group
Zazz Energy
Zinzino
All
Company News
Deal News
Equity Research
Events
In the Media
Insights
Macro and Markets
09 Nov 2017
Analysis, Karolinska Development: Rising Temperature
Equity Research
08 Nov 2017
Globalscope Newsletter 2017 H2
Company News
07 Nov 2017
Analysis, Kontigo: Continued growth
Equity Research
02 Nov 2017
Analysis, Sonetel: Focus on the next step
Equity Research
01 Nov 2017
Analysis, Serneke: Focus on public clients
Equity Research
31 Oct 2017
Analysis, GHP Specialty Care: Balancing Act
Equity Research
30 Oct 2017
Analysis, Lammhults: Danish operations a drag
Equity Research
27 Oct 2017
Review: Serneke Q3 2017
Equity Research
26 Oct 2017
Analysis, Absolicon: Solar Panels for the Future
Equity Research
26 Oct 2017
Analysis Multidocker: Acquisitions should decrease purchasing costs
Equity Research
26 Oct 2017
Analysis Hanza: A significant better third quarter
Equity Research
25 Oct 2017
Analysis, Xbrane: Delivery and progress in the lab
Equity Research
25 Oct 2017
Analysis, Wilson Therapeutics: Green Light for Phase III
Equity Research
24 Oct 2017
Venture Lounge at Merck Innovation Center
Company News
18 Oct 2017
Analysis, myTaste: Acquisition creates value
Equity Research
12 Oct 2017
Analysis, Follicum: Dawning Opportunity in Hair Growth
Equity Research
11 Oct 2017
Elgemyr: "Crypto currencies are here to stay"
In the Media
10 Oct 2017
Analysis, Brighter: 10,9,8.... launch
Equity Research
05 Oct 2017
StarTec sells majority stake to AnaCap and Heidelpay (now known as Unzer)
Deal News
04 Oct 2017
Analysis, Maxkompetens: Undiscovered growth
Equity Research
1
…
60
61
62
63
64
…
76